These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38233074)

  • 21. TNF-α and TGF-β counter-regulate PD-L1 expression on monocytes in systemic lupus erythematosus.
    Ou JN; Wiedeman AE; Stevens AM
    Sci Rep; 2012; 2():295. PubMed ID: 22389764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low expressions of PD-L1 and CTLA-4 by induced CD4
    Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
    Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The PD-1 with PD-L1 Axis Is Pertinent with the Immune Modulation of Atrial Fibrillation by Regulating T Cell Excitation and Promoting the Secretion of Inflammatory Factors.
    Chang G; Chen Y; Liu Z; Wang Y; Ge W; Kang Y; Guo S
    J Immunol Res; 2022; 2022():3647817. PubMed ID: 35600045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exhausted T cells in systemic lupus erythematosus patients in long-standing remission.
    Lima G; Treviño-Tello F; Atisha-Fregoso Y; Llorente L; Fragoso-Loyo H; Jakez-Ocampo J
    Clin Exp Immunol; 2021 Jun; 204(3):285-295. PubMed ID: 33475152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patients with systemic lupus erythematosus show increased proportions of CD19
    Zhu Q; Li Y; Zhang L; Wang M; Chen Z; Shi J; Li J; Li B; Li Z; Wang Y; Xie C
    Clin Rheumatol; 2021 Jan; 40(1):151-165. PubMed ID: 32542581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rituximab in Systemic Lupus Erythematosus: Transient Effects on Autoimmunity Associated Lymphocyte Phenotypes and Implications for Immunogenicity.
    Faustini F; Sippl N; Stålesen R; Chemin K; Dunn N; Fogdell-Hahn A; Gunnarsson I; Malmström V
    Front Immunol; 2022; 13():826152. PubMed ID: 35464461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactive glia promote development of CD103
    Prasad S; Hu S; Sheng WS; Chauhan P; Lokensgard JR
    Immun Inflamm Dis; 2018 Jun; 6(2):332-344. PubMed ID: 29602245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenicity of functionally activated PD-1
    Sasaki H; Umezawa N; Itakura T; Iwai H; Yasuda S
    J Autoimmun; 2024 Jan; 142():103131. PubMed ID: 37931332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased percentages of PD-1 on CD4+ T cells is associated with higher INF-γ production and altered IL-17 production in patients with systemic lupus erythematosus.
    Dolff S; Quandt D; Feldkamp T; Jun C; Mitchell A; Hua F; Specker C; Kribben A; Witzke O; Wilde B
    Scand J Rheumatol; 2014; 43(4):307-13. PubMed ID: 25088926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholangiocarcinoma cells.
    Suriyo T; Fuangthong M; Artpradit C; Ungtrakul T; Sricharunrat T; Taha F; Satayavivad J
    Eur J Pharmacol; 2021 Apr; 897():173960. PubMed ID: 33617828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BAFFR expression in circulating T follicular helper (CD4
    Sagrero-Fabela N; Ortíz-Lazareno PC; Salazar-Camarena DC; Cruz A; Cerpa-Cruz S; Muñoz-Valle JF; Marín-Rosales M; Alvarez-Gómez JA; Palafox-Sánchez CA
    Lupus; 2023 Aug; 32(9):1093-1104. PubMed ID: 37460408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations of circulating CXCR3
    Han L; Yang X; Yu Y; Wan W; Lv L; Zou H
    Mod Rheumatol; 2019 May; 29(3):461-469. PubMed ID: 29694256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PD-1+CXCR5-CD4+T cells are correlated with the severity of systemic lupus erythematosus.
    Lin J; Yu Y; Ma J; Ren C; Chen W
    Rheumatology (Oxford); 2019 Dec; 58(12):2188-2192. PubMed ID: 31180450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Latent Tuberculosis Infection and Associated Factors in Patients with Systemic Lupus Erythematosus: a Multicenter, Cross-Sectional Study.
    Zhang L; Ma Y; Jiang N; Zou X; Zhang Y; Zhang F; Zeng X; Zhao Y; Liu S; Zuo X; Wu H; Wu L; Li H; Zhang Z; Chen S; Zhu P; Zhang M; Qi W; Liu Y; Liu H; Shi X; Liu X
    Microbiol Spectr; 2023 Jun; 11(3):e0084823. PubMed ID: 37158726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunoregulatory axis (programmed death-1/programmed death ligand-1) on CD4+ T cells in lupus nephritis: association with vitamin D and chemokine C-X-C motif ligand 12.
    Youssry S; Hussein A; Moaaz M
    Microbiol Immunol; 2021 Sep; 65(9):392-399. PubMed ID: 34081342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glial cells suppress postencephalitic CD8+ T lymphocytes through PD-L1.
    Schachtele SJ; Hu S; Sheng WS; Mutnal MB; Lokensgard JR
    Glia; 2014 Oct; 62(10):1582-94. PubMed ID: 24890099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IFN-γ treatment protocol for MHC-I
    Stifter K; Krieger J; Ruths L; Gout J; Mulaw M; Lechel A; Kleger A; Seufferlein T; Wagner M; Schirmbeck R
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32868392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Programmed Death-Ligand 1 Expression Potentiates the Immune Modulatory Function Of Myeloid-Derived Suppressor Cells in Systemic Lupus Erythematosus.
    Park MJ; Baek JA; Choi JW; Jang SG; Kim DS; Park SH; Cho ML; Kwok SK
    Front Immunol; 2021; 12():606024. PubMed ID: 33986739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blocking of programmed cell death-ligand 1 (PD-L1) expressed on endothelial cells promoted the recruitment of CD8
    Li Q; Wei S; Li Y; Wu F; Qin X; Li Z; Li J; Chen C
    Inflamm Res; 2023 Apr; 72(4):783-796. PubMed ID: 36867228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.